Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance

OBJECTIVE: The goal of this study was to monitor imatinib mesylate therapeutically in the Tumor Biology Laboratory, Department of Hematology and Hemotherapy, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (USP). A simple and sensitive method to quantify imatinib and its meta...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rezende, Vinícius Marcondes, Rivellis, Ariane Julio, Gomes, Melissa Medrano, Dörr, Felipe Augusto, Novaes, Mafalda Megumi Yoshinaga, Nardinelli, Luciana, Costa, Ariel Lais de Lima, Chamone, Dalton de Alencar Fisher, Bendit, Israel
Format: Artigo
Langue:Inglês
Publié: Associação Brasileira de Hematologia e Hemoterapia 2013
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3672119/
https://ncbi.nlm.nih.gov/pubmed/23741187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5581/1516-8484.20130030
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires